Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Personalis Inc | PSNL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.26 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.26 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.8906 - 2.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.26 | USD |
Personalis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.63M | 50.50M | - | 73.48M | -108.3M | -2.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Personalis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSNL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.235 | 1.32 | 1.18 | 1.24 | 260,397 | 0.025 | 2.02% |
| 1 Month | 1.50 | 1.54 | 1.18 | 1.34 | 229,688 | -0.24 | -16.00% |
| 3 Months | 1.54 | 1.80 | 1.12 | 1.44 | 339,527 | -0.28 | -18.18% |
| 6 Months | 0.98 | 2.38 | 0.8906 | 1.47 | 510,188 | 0.28 | 28.57% |
| 1 Year | 2.45 | 2.60 | 0.8906 | 1.60 | 370,541 | -1.19 | -48.57% |
| 3 Years | 22.79 | 28.47 | 0.8906 | 7.74 | 444,213 | -21.53 | -94.47% |
| 5 Years | 23.70 | 53.46 | 0.8906 | 14.75 | 492,364 | -22.44 | -94.68% |
Personalis Description
| Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. |
